Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Structure Therapeutics Inc increased its cash reserves by 397.46%, or 103.70m. Cash Flow from Financing totalled 451.53m or -- of revenues. In addition the company used 79.49m for operations while cash used for investing totalled 268.34m.
Cash flow per share | -2.20 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 15.66 |
---|---|
Tangible book value per share | 15.66 |
More ▼
Balance sheet in USDView more
Current ratio | 27.63 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼